Response to bendamustine is associated with a survival advantage in a heavily pretreated patients with AL amyloidosis

Paolo Milani, Stefan Schönland, Giovanni Palladini, Christoph Kimmich, Marco Basset, Francesca Russo, Andrea Foli, Stefano Perlini, Tilmann Bochtler, Anthony D. Ho, Giampaolo Merlini, Ute Hegenbart

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)56-57
Number of pages2
Publication statusPublished - Mar 16 2017

ASJC Scopus subject areas

  • Internal Medicine

Cite this